Cargando…
Editorial: Novel and emerging therapies in heart failure
Autores principales: | Giamouzis, Grigorios, Xanthopoulos, Andrew, Boudoulas, Konstantinos Dean, Karagiannis, Georgios, Skoularigis, John, Triposkiadis, Filippos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079209/ https://www.ncbi.nlm.nih.gov/pubmed/37034331 http://dx.doi.org/10.3389/fcvm.2023.1179352 |
Ejemplares similares
-
The Interventricular Septum: Structure, Function, Dysfunction, and Diseases
por: Triposkiadis, Filippos, et al.
Publicado: (2022) -
Heart failure with preserved ejection fraction: A distinct heart failure phenotype?
por: Triposkiadis, Filippos, et al.
Publicado: (2022) -
Heart failure with reduced, mildly reduced, or preserved left ventricular ejection fraction: Has reasoning been lost?
por: Xanthopoulos, Andrew, et al.
Publicado: (2022) -
The effect of SGLT-2i administration on red blood cell distribution width in patients with heart failure and type 2 diabetes mellitus: A randomized study
por: Katsiadas, Nikolaos, et al.
Publicado: (2022) -
ACE2, the Counter-Regulatory Renin–Angiotensin System Axis and COVID-19 Severity
por: Triposkiadis, Filippos, et al.
Publicado: (2021)